安必平(688393.SH):宮頸細胞學人工智能輔助系統正在三類證註冊申報階段
格隆匯12月30日丨安必平(688393.SH)披露投資者關係活動記錄表顯示,公司的宮頸細胞學人工智能輔助系統正在三類證註冊申報階段,該產品最主要解決的問題是篩陰工作。國內病理醫生比較缺乏,細胞學診斷特別依賴醫生的判讀,公司預期的場景是,通過AI完成大部分的篩陰工作,進而讓醫生把主要精力集中在可疑點位,提高診斷效率和診斷準確性。該產品已標註視野圖像超100萬,標註細胞超260萬,在9個醫學中心的第三方測試中均有較高的特異度。目前公司的“細胞學試劑+製片染色設備+掃描儀+AI判讀”智能化整體篩查方案已經在醫院病理科推廣試用,可以減輕細胞學醫生的工作量。該產品同時獲得了美國ASCCP的科技創新獎,相關論文也在了學術期刊《Modern Pathology》和《Acta Obstetricia et Gynecologica Scandinavica》發表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.